Skip to main content
Caplight Logo









NanoSomiX, Inc.

NanoSomiX, Inc.

Private
Aliso Viejo, CaliforniaHealthcare & Life Scienceshttps://www.nanosomix.com/

Total Funding Raised

$2M

Company Overview

NanoSomiX, Inc. is a biotechnology company that develops non-invasive blood-based diagnostic assays using brain-derived exosomes to detect and monitor neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

brain-derived exosomesBDEliquid biopsyneurological diagnosticsblood-based assaysCLIA laboratorybiomarker discoveryAlzheimer's diagnosticsexosome isolationneurodegenerative disease researchcontract research organizationCROnon-invasive testingimmunoassayELISA

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NanoSomiX, Inc. Comparables

Compare NanoSomiX, Inc. with similar companies based on industry and business-model similarity.

NanoSomiX, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NeuroDex
91%
C2N Diagnostics
83%
FYR Diagnostics
82%

NanoSomiX, Inc. Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

NanoSomiX, Inc. Investors

Notable investors and investment history

NanoSomiX, Inc. investors
InvestorRounds
Friends & Family CapitalAngel

Recent news

Latest coverage and updates

  • is_developingJul 30, 2026

    Nanosomix, Inc. is developing EV-based immunoassays.

  • is_developingJul 30, 2026

    Nanosomix, Inc. is planning to develop next-generation immunoassays for neurodegenerative diseases.

  • is_developingJul 22, 2026

    Nanosomix, Inc. is developing blood tests for brain diseases on Jul 22nd '26.

  • is_developingJul 22, 2026

    Nanosomix, Inc. is developing extracellular vesicle-enabled immunoassays for neurodegenerative diseases on Jul 22nd '26.

  • partners_withJul 22, 2026

    Nanosomix, Inc. partnered with Beckman Coulter, Inc. on Jul 22nd '26.

NanoSomiX, Inc. Filings

Explore SEC and related filing metadata, where available.

NanoSomiX, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NanoSomiX, Inc.'s valuation, stock price, and market status.

Is NanoSomiX, Inc. a public or private company?

NanoSomiX, Inc. is a private company.

What is the current stock price of NanoSomiX, Inc.?

NanoSomiX, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is NanoSomiX, Inc. worth (valuation)?

Valuation information for NanoSomiX, Inc. is not publicly available.

Can I buy NanoSomiX, Inc. stock?

NanoSomiX, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NanoSomiX, Inc.'s last funding round?

Funding round information for NanoSomiX, Inc. is not publicly available.

Who are the main investors in NanoSomiX, Inc.?

Key investors in NanoSomiX, Inc. include Friends & Family Capital.

Will NanoSomiX, Inc. IPO soon?

No public IPO plans have been announced for NanoSomiX, Inc..

How can I track NanoSomiX, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NanoSomiX, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAliso Viejo, California
Year Founded2014
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?